Boothbay Fund Management, LLC Akebia Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

  • $4.17 Billion
  • Q1 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.32 - $0.67 $78,816 - $165,021
-246,300 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.72 - $2.93 $165,943 - $675,297
230,477 Added 1456.59%
246,300 $177,000
Q4 2021

Feb 14, 2022
SELL
$2.26 - $3.34 $134,282 - $198,452
-59,417 Reduced 78.97%
15,823 $36,000
Q3 2021

Nov 15, 2021
BUY
$2.35 - $3.88 $57,499 - $94,935
24,468 Added 48.19%
75,240 $217,000
Q2 2021

Aug 16, 2021
BUY
$2.83 - $4.2 $46,610 - $69,174
16,470 Added 48.01%
50,772 $192,000
Q1 2021

May 17, 2021
BUY
$2.92 - $5.06 $43,712 - $75,748
14,970 Added 77.44%
34,302 $116,000
Q4 2020

Feb 12, 2021
SELL
$2.22 - $3.78 $2,859 - $4,868
-1,288 Reduced 6.25%
19,332 $54,000
Q3 2020

Nov 16, 2020
BUY
$2.39 - $13.08 $49,281 - $269,709
20,620 New
20,620 $52,000
Q4 2019

Feb 14, 2020
SELL
$3.16 - $6.73 $224,360 - $477,830
-71,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$3.55 - $5.4 $252,050 - $383,400
71,000 New
71,000 $278,000
Q2 2019

Aug 14, 2019
SELL
$4.1 - $8.05 $426,399 - $837,200
-104,000 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$5.41 - $8.73 $206,380 - $333,032
38,148 Added 57.93%
104,000 $852,000
Q4 2018

Feb 14, 2019
BUY
$5.39 - $9.15 $354,942 - $602,545
65,852 New
65,852 $364,000

Others Institutions Holding AKBA

# of Institutions
127
Shares Held
56.7M
Call Options Held
937K
Put Options Held
743K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $188M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email